Cardiol Therapeutics Inc.   Report issue

For profit Phase 3
Founded: Oakville CA United States (2017)

Organization Overview

First Clinical Trial
2020
NCT04615949
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Cardiol Therapeutics Inc.